Zentiva Group, a.s., headquartered in the Czech Republic, is a prominent player in the pharmaceutical industry, specialising in generic and over-the-counter medicines. Founded in 1998, the company has established a strong presence across Central and Eastern Europe, focusing on delivering high-quality, affordable healthcare solutions. Zentiva's core product offerings include a diverse range of generic pharmaceuticals, which are distinguished by their commitment to quality and accessibility. The company has achieved significant milestones, including expanding its portfolio and enhancing its manufacturing capabilities, positioning itself as a trusted provider in the market. With a dedication to innovation and patient-centric solutions, Zentiva continues to strengthen its market position, contributing to improved health outcomes across the regions it serves.
How does Zentiva Group, a.s.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zentiva Group, a.s.'s score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Zentiva Group, a.s. reported total carbon emissions of approximately 54,749 kg CO2e. This includes Scope 1 emissions of about 3,931 kg CO2e, Scope 2 emissions of approximately 3,264 kg CO2e, and significant Scope 3 emissions totalling around 50,818 kg CO2e. The Scope 3 emissions breakdown reveals substantial contributions from categories such as purchased goods and services (about 43,554 kg CO2e) and end-of-life treatment of sold products (approximately 924,000 kg CO2e). Zentiva has set ambitious climate commitments, aiming for carbon neutrality in Scope 1 and Scope 2 emissions by 2030. This commitment is contingent upon advancements in process technology and operational practices. Furthermore, the company has established science-based targets (SBTi) to reduce absolute Scope 1 and 2 emissions by 63% by 2034 from a 2021 baseline, and to achieve a 90% reduction by 2050. For Scope 3 emissions, a similar reduction target of 63% by 2034 and 90% by 2050 has been set, with the 2024 baseline year. Zentiva's overall net-zero target encompasses all greenhouse gas emissions across its value chain by 2050, aligning with the 1.5°C climate goal. The company's emissions data is cascaded from its parent organization, Zentiva Group, a.s., ensuring a comprehensive approach to sustainability and climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2024 | |
|---|---|---|
| Scope 1 | 305,480,000 | 0,000 |
| Scope 2 | 79,081,000 | 0,000 |
| Scope 3 | - | 00,000 |
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "End-of-Life Treatment of Sold Products" being the largest emissions source at 1818% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zentiva Group, a.s. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Zentiva Group, a.s.'s sustainability data and climate commitments
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.